Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome

Medicine (United States)

Volumn 96, Issue 14, 2017, Pages

  Sardu, Celestino ^a,b   Santamaria, Matteo ^b   Funaro, Stefania ^b   Sacra, Cosimo ^b   Barbieri, Michelangela ^a   Paolisso, Pasquale ^a   Marfella, Raffaele ^a   Paolisso, Giuseppe ^a   Rizzo, Maria Rosaria ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Giovanni Paolo II Research Foundation   (Italy)

Author keywords

cardiac resynchronization therapy with a defibrillator; heart failure; metabolic syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IVABRADINE; LOOP DIURETIC AGENT; ORAL ANTIDIABETIC AGENT; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART PACING; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CASE CONTROL STUDY; COMPLICATION; HEART MUSCLE CONDUCTION SYSTEM; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PATHOPHYSIOLOGY;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CASE-CONTROL STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 85017650094     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000006558     Document Type: Article

References (31)

1. Grundy SM, Becker D, Clark LT, et al. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Adult Treatment Panel III. Final report. Circulation 2002;106:3143-421.
2. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50.
3. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78.
4. Beltrán-Sánchez H, Harhay MO, Harhay MM, et al. Prevalence and trends of metabolic syndrome in the adult U. S. population, 1999-2010. J Am Coll Cardiol 2013;62:697-703.
5. Wang J, Sarnola K, Ruotsalainen S, et al. The metabolic syndrome predicts incident congestive heart failure: a 20-year follow-up study of elderly Finns. Atherosclerosis 2010;210:237-42.
6. Suzuki T, Katz R, Jenny NS, et al. Metabolic syndrome, inflammation, and incident heart failure in the elderly. The Cardiovascular Health Study. Circ Heart Fail 2008;1:242-8.
7. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the national health and nutrition examination survey II mortality study. Atherosclerosis 2004;173: 309-14.
8. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361:1329-38.
9. Epstein AE, Di Marco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2013;61: e6-75. 19.
10. Brignole M, Auricchio A, Baron-Esquivias G. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34: 2281-329.
11. Sardu C, Carreras G, Katsanos S, et al. Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation. BMC Cardiovasc Disord 2014;6:176.
12. Poirier P, Giles TD, Bray TA, et al. AHA Scientific Statement. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, andMetabolism. Circulation 2006;113:898-918.
13. Maisel WH. Physician management of pacemaker and implantable cardioverter defibrillator advisories. Pacing Clin Electrophysiol 2004; 27:437-42.
14. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112: 841-8.
15. Prochazka A, Korpas D. Monitoring biventricular pacing parameters depending on the left ventricle lead configuration. Exp Clin Cardiol 2013;18:85-8.
16. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001;7:176-82.
17. Mahajan R, Lau DH, Sanders P. Impact of obesity on cardiac metabolism, fibrosis, and function. Trends Cardiovasc Med 2015;25: 119-26.
18. Mahajan R, Lau DH, Brooks AG, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 2015;66:1-1.
19. Santulli G, Pagano G, Sardu C, et al. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest 2015; 125:1968-78.
20. Chi C, WeiH, Li-Gang D, et al. Association of body 450 mass index with cardiac reverse remodeling and long-term outcome in advanced heart failure patients with cardiac resynchronization therapy. Circ J 2014; 78:2899-907.
21. Hsu JC, Solomon SD, Bourgoun M, et al. MADiT-CRT Executive Committee. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADiTCRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol 2012;59:2366-73.
22. Fantoni C, Regoli F, Ghanem A, et al. Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail 2008;10:298-307.
23. Martin D T, McNitt S, Nesto R W, et al. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADiT-CRT). Circ Heart Fail 2011;4:332-8.
24. Sardu C, Marfella R, Santulli G. Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. J Cardiovasc Transl Res 2014;7:362-8.
25. Lebovitz HE. Insulin: potential negative consequences of early routine use in patients with type 2 diabetes. Diabetes Care 2011;34(Suppl 2): 225-30.
26. Poirier P, Lemieux I,Mauriege P, et al. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension 2005;45:363-7.
27. Landsberg L, Troisi R, Parker D, et al. Obesity, blood pressure, and the sympathetic nervous system. Ann Epidemiol 1991;1:295-303.
28. Sardu C, Barbieri M, Rizzo MR, et al. Cardiac resynchronization therapy outcomes in type 2 diabetic patients: role of microRNA changes. J Diabetes Res 2016;2016:7292564.
29. Sardu C, Marfella R, Santulli G, et al. Functional role of miRNA in cardiac resynchronization therapy. Pharmacogenomics 2014;8:1159-68.
30. Mohanty S, Mohanty P, Di Biase L, et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol 2012;59:1295-301.
31. Sardu C, Santamaria M, Rizzo MR, et al. Telemonitoring in heart failure patients treated by cardiac resynchronization therapy with defibrillator (CRT-D): the TELECART Study. Int J ClinPract 2016;70:569-76.